TrialmBio2022

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

Luther A Bartelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.